Functional magnetic resonance imaging of the brain's response to pain in patients with a diagnosis of fibromyalgia;Resonancia magnética funcional de la respuesta cerebral al dolor en pacientes con diagnóstico de fibromialgia

Psiquiatria Biologica

Volumn 13, Issue 2, 2006, Pages 39-46

  Deus, Joan ^a,b   Pujol, Jesús ^a   Bofill, Jaume ^c   Villanueva, Alicia ^a   Ortiz, Hector ^a   Cámara, Estela ^d   Soriano Mas, Carles ^a   Cardoner, Narcís ^a,d   Vallejo, Julio ^d  

^a Institut d'Alta Tecnologia   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Péritos Médicos Titulados de Tarragona   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Anterior cingulum; Chronic pain; Fibromyalgia; Functional magnetic resonance imaging; Insula; Pain perception

Indexed keywords

ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROMYALGIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; PAIN; PAIN ASSESSMENT; SENSORIMOTOR CORTEX; THUMB;

EID: 33745433125     PISSN: 11345934     EISSN: 15788962     Source Type: Journal    
DOI: 10.1016/s1134-5934(06)75337-4     Document Type: Article

References (52)

1. Peyron R, Laurent B, García-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol Clin. 2000;30:263-88.
2. Casey KL. Forebrain mechanisms of nociception and pain: analysis through imaging. Proc Natl Acad Sci. 1999;96:7688-74.
3. Treede RD, Kenshalo DR, Gracely RH, Jones AKP. The cortical representation of pain. Pain. 1999;79:105-11.
4. Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science. 2000;288:1769-72.
5. Derbyshire SWG, Jones AKP, Creed F, et al. Cerebral responses to noxious thermal stimulation in chronic low back pain patients and normal controls. Neuroimage. 2002;16:158-68.
6. Derbyshire SWG, Whalley MG, Stenger A, Oakley DA. Cerebral activation during hypnotically induced and imagined pain. Neuroimage. 2004;23:392-401.
7. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002;46:1333-43.
8. Gracely RH, Geisser ME, Giesecke T, et al. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain. 2004;127:835-43.
9. Arroyo JF, Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol. 1993;20:1925-31.
10. 2 laser stimulation in subjects with fibromyalgia syndrome. Pain. 1994;58:185-93.
11. Lautenbacher S, Rollman GB, McCain GA. Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain. 1994;591:45-53.
12. Kosek E, Ekholm J, Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain. 1996;68:375-83.
13. Yunus MB. Central sensitivity syndromes: a unified concept for fibromyalgia and other similar maladies. J Indian Rheum Assoc. 2000;8:27-33.
14. Cathebras P, Lauwers A, Rousset H. Fibromyalgia. A critical review. Ann Med Intern (Paris). 1998;149:406-14.
15. Goldenberg DL. Fibromyalgia: to diagnose or not. Is that still the question? J Rheumatol. 2004;31:633-5.
16. Jeschonneck M, Grohmann G, Hein G, Sprott H. Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatol. 2000;39:917-21.
17. Forseth K, Gran JT. Management of fibromyalgia. What are the best treatment choices? Drugs. 2002;62:577-92.
18. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160-72.
19. Consensus Document on Fibromyalgia: The Copenhagen Declaration. J Musculoskel Pain. Vol. 1. New York: The Haworth Press, Inc.; 1993.
20. Wolfe F, Ross K, Anderson J, Russell U, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
21. Collado A, Alijotas J, Benito P, Alegre C, Romera M, Sanudo I, et al. Documento de consenso sobre el diagnóstico y tratamiento de la fibromialgia en Cataluña. Med Clin (Barc). 2002;118:745-9.
22. Valverde M. Prevalencia de la fibromialgia en la población española. Estudio EPISER [resumen]. Rev Esp Reumatol. 2000;27:157.
23. Van Houdenhove B, Neerinckx E, Lysens R, et al. Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics. Psychosomatics. 2000;42:21-8.
24. Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scad J Rheumatol. 1986;15:165-73.
25. Hein G, Franke S. Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia? Rheumatol. 2002;41:1163-7.
26. Smythe H. Fibrositis syndrome: a historical perspective. J Rheumatol. 1989;16 Suppl 19:2-6.
27. 31P magnetic resonance spectroscopy in fibromyalgic muscle. Rheumatol. 2000;39:1121-5.
28. Al-Allaf AW, Dunbar KL, Hallum NS, Nosratzadeh B, Templeton KD, Pullar T. A case-control study examining the role of physical trauma in the onset of fibromyalgia syndrome. Rheumatol. 2002;41:450-3.
29. Nicassio PM, Moxham EG, Schuman CE, Gevirtz RN. The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain. 2002;100:271-9.
30. Doughan A, Bino M, Kawar J, Ahmed T. Psychological aspects of primary fibromyalgia syndrome. Am J Psychiatry. 1995;6:176-85.
31. Russell IJ. Neurochemical pathogenesis of fibromyalgia syndrome. J Musculoskel Pain. 1996;4:61-92.
32. Russell IJ. Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci. 1998;315:377-85.
33. Larson AA, Giovengo SL, Russell IJ, et al. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain. 2000;87:201-11.
34. 3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatol. 2001;40:290-6.
35. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatol. 2001;40:743-9.
36. Panerai AE, Vecchiet J, Panzeri P, et al. Peripheral blood mononuclear cell B-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report. Clin J Pain. 2002;18:270-3.
37. Russell IJ. Pathogenesis of fibromyalgia: the neurohormonal hypothesis. J Musculoskel Pain. 1994;2:73-86.
38. Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand J Rheumatol. 2000;29 Suppl 113:8-12.
39. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum. 1995;38:926-38.
40. Kwiatek R, Barnden L, Tedman R, et al. Regional blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum. 2000;43:2823-33.
41. Yunus MB, Young CS, Saeed A, Mountz JM, Aldag JC. Positron emission tomography in patients with fibromialgia syndrome and healthy controls. Arthritis Rheum. 2004;51:513-8.
42. Wik G, Fischer H, Bragee B, Kristianson M, Fredrikson M. Retrosplenial cortical activation in the fibromyalgia syndrome. Neuroreport. 2003;14:619-21.
43. Giesecke T, Gracely RH, Grant MA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum. 2004;50:613-23.
44. Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol. 2004;31:364-78.
45. Petzke F, Gracely RH, Park KM, Ambrose K, Clauw DJ. What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol. 2003;30:567-74.
46. Gracely RH, Lota L, Walter DJ, Dubner R. A multiple random staircase method of psychophysical pain assessment. Pain. 1988;32:55-63.
47. Pujol J, Vendrell P, Deus J, Mataró M, Capdevila A, Martí-Vilalta JL. Estudio de la actividad cerebral con resonancia magnética funcional. Med Clin (Barc). 1995;104:1-5.
48. Pujol J, Conesa G, Deus J, López-Obarrio L, Isamat F, Capdevila A. Clinical application of functional magnetic resonance imaging in presurgical identification of the central sulcus. J Neurosurg. 1998;88:863-9.
49. Pujol J, Deus J, Losilla JM, Capdevila A. Cerebral lateralization of language in normal left-handed people studied by functional MRI. Neurology. 1999;52:1038-43.
50. McCarthy G, Puce A, Luby M, Beiger A, Allison T. Magnetic resonance imaging studies of functional brain activation: analysis and interpretation. En: Hashimoto I, Okada YC, Ogawa S, editors. Visualization of information processing in the human brain: recent advances in MEG and functional MRI (EEG Suppl. 47). Amsterdam: Elsevier; 1996. p. 15-31.
51. Pujol J, Roset-Llobet J, Rosinés-Cubells D, et al. Brain cortical activation during guitar-induced hand dystonia studied by functional MRI. Neuroimage. 2000;12:257-67.
52. Sawamoto N, Honda M, Okada T, et al. Expectation of pain enhances responses to nonpainful somatosensory stimulation in the anterior cingulate cortex and parietal operculum/posterior insula: an event-related functional magnetic resonance imaging study. J Neurosci. 2000;20:7438-45.